KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesR&D In ProcessShares RepurchasedShort-Term Debt issuances
Ratios

Eli Lilly (LLY) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Eli Lilly (LLY) over the last 13 years, with Q1 2022 value amounting to $950.6 million.

  • Eli Lilly's Shares Outstanding fell 92.52% to $950.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $950.6 million, marking a year-over-year decrease of 92.52%. This contributed to the annual value of $954.1 million for FY2021, which is 30.94% down from last year.
  • Per Eli Lilly's latest filing, its Shares Outstanding stood at $950.6 million for Q1 2022, which was down 92.52% from $954.1 million recorded in Q4 2021.
  • In the past 5 years, Eli Lilly's Shares Outstanding ranged from a high of $1.1 billion in Q1 2018 and a low of $950.6 million during Q1 2022
  • In the last 5 years, Eli Lilly's Shares Outstanding had a median value of $958.1 million in 2019 and averaged $985.5 million.
  • As far as peak fluctuations go, Eli Lilly's Shares Outstanding plummeted by 1082.15% in 2019, and later rose by 26.68% in 2021.
  • Quarter analysis of 5 years shows Eli Lilly's Shares Outstanding stood at $1.1 billion in 2018, then decreased by 9.42% to $958.1 million in 2019, then decreased by 0.1% to $957.1 million in 2020, then fell by 0.31% to $954.1 million in 2021, then fell by 0.37% to $950.6 million in 2022.
  • Its last three reported values are $950.6 million in Q1 2022, $954.1 million for Q4 2021, and $957.1 million during Q3 2021.